Skip to main content

Elevance Health, Inc. company profile

  • ELV · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$429.69−0.05%Close 13 Nov 2026 · Market value $96.13B

About Elevance Health, Inc.

Elevance Health is a health company that provides medical, pharmacy, and behavioral health services through managed care health plans and related businesses. It serves approximately 45.2 million medical members as of December 31, 2025, across Individual, Employer Group, Medicaid, and Medicare markets, and provides administrative and fee-based services to customers including self-funded employers and unaffiliated health plans. Its operations are organized into Health Benefits, CarelonRx (pharmacy services), Carelon Services (care management, behavioral health, and analytics), and Corporate & Other segments. The company is an independent licensee of the Blue Cross and Blue Shield Association and is licensed to conduct insurance operations in all 50 states, the District of Columbia, and Puerto Rico. It also provides services to the federal government, including administration of the Federal Employee Program.

A summary of the business section of the company's latest annual report, filed 6 Feb 2026.

Company facts

TickerELV · NYSE
SectorInsurance
IndustryManaged Health Care
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1156039
Latest annual report10-K, filed 6 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Gail K. BoudreauxPresident and CEO · Director443KOpen-market purchase, 17 Jul 2026
Peter D. HaytaianEVP & Pres Carelon & CarelonRx118KShares withheld for tax, 3 Mar 2026
Felicia F. NorwoodEVP &Chief Health Benefits Ofr97.4KShares withheld for tax, 3 Mar 2026
Morgan KendrickEVP & President, Commercial40.2KOpen-market sale, 6 Mar 2026
Mark KayeEVP & CFO23.0KOpen-market sale, 22 Oct 2026
Lewis Hay, IIIDirector11.5KGrant or award, 13 May 2026
Robert L. Dixon, Jr.Director10.3KOpen-market sale, 11 Jun 2026
R. Kerry ClarkDirector9.6KGrant or award, 14 May 2025
Ramiro G. PeruDirector9.3KOpen-market purchase, 17 Jul 2026
Ryan M. SchneiderDirector6.6KGrant or award, 13 May 2026
Antonio F. NeriDirector4.9KGrant or award, 13 May 2026
Bahija JallalDirector4.8KGrant or award, 13 May 2026
Susan D. DeVoreDirector3.5KGrant or award, 13 May 2026
Deanna D. StrableDirector1.6KGrant or award, 13 May 2026
Steven H. CollisDirector639Grant or award, 13 May 2026
LAVU RATNAKAREVP & Chief Digital Info Ofr—Open-market sale, 5 Nov 2026
Wessling Erin MEVP & Chief Legal Officer—Shares withheld for tax, 3 Sep 2026
Craig Ryan REVP & Chief HR Officer—Shares withheld for tax, 2 Sep 2026
Penczek Ronald WCAO & Controller—Open-market sale, 12 Jun 2026
Amy W. SchulmanDirector—Grant or award, 13 May 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

ELV in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.